Maksym Pikul | Medicine and Dentistry | Best Researcher Award Posted on 04/09/202404/09/2024 by ScienceFather Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award Scientific Co-worker at University Hospital Cologne, Germany Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award. Profile Scopus Profile ORCID Profile Education Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer. Professional Experience Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field. Research Interest Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies. Research Skills Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes. Award and Recognition Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise. Conclusion Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology. Publication Top Notes Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B. Year: 2024 Journal: Urologic Oncology: Seminars and Original Investigations Volume: 42 Issue: 2 Pages: 31.e9–31.e15 Citations: 1 Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E. Year: 2023 Journal: Journal of Cancer Research and Clinical Oncology Volume: 149 Issue: 7 Pages: 3131–3137 Citations: 1 Title: Modification of Fast-Track Surgery During Partial Nephrectomy Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O. Year: 2023 Journal: Ukrainian Journal of Nephrology and Dialysis Volume: 80 Issue: 4 Pages: 24–33 Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma Authors: Pikul, M.V., Stakhovsky, E.O. Year: 2023 Journal: Central European Journal of Urology Volume: 76 Issue: 2 Pages: 116–122 Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M. Year: 2022 Journal: Experimental Oncology Volume: 44 Issue: 1 Pages: 166–172 Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V. Year: 2021 Journal: Experimental Oncology Volume: 43 Issue: 2 Pages: 98–103 Citations: 1 Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O. Year: 2021 Journal: Advances in Urology Volume: 2021 Article ID: 6674637 Citations: 6 Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O. Year: 2020 Journal: Experimental Oncology Volume: 42 Issue: 3 Pages: 224–227 Citations: 3 Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O. Year: 2020 Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960) Volume: 73 Issue: 5 Pages: 988–993 Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E. Year: 2019 Journal: Experimental Oncology Volume: 41 Issue: 1 Pages: 76–79
Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award. Profile Scopus Profile ORCID Profile Education Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer. Professional Experience Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field. Research Interest Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies. Research Skills Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes. Award and Recognition Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise. Conclusion Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology. Publication Top Notes Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B. Year: 2024 Journal: Urologic Oncology: Seminars and Original Investigations Volume: 42 Issue: 2 Pages: 31.e9–31.e15 Citations: 1 Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E. Year: 2023 Journal: Journal of Cancer Research and Clinical Oncology Volume: 149 Issue: 7 Pages: 3131–3137 Citations: 1 Title: Modification of Fast-Track Surgery During Partial Nephrectomy Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O. Year: 2023 Journal: Ukrainian Journal of Nephrology and Dialysis Volume: 80 Issue: 4 Pages: 24–33 Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma Authors: Pikul, M.V., Stakhovsky, E.O. Year: 2023 Journal: Central European Journal of Urology Volume: 76 Issue: 2 Pages: 116–122 Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M. Year: 2022 Journal: Experimental Oncology Volume: 44 Issue: 1 Pages: 166–172 Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V. Year: 2021 Journal: Experimental Oncology Volume: 43 Issue: 2 Pages: 98–103 Citations: 1 Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O. Year: 2021 Journal: Advances in Urology Volume: 2021 Article ID: 6674637 Citations: 6 Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O. Year: 2020 Journal: Experimental Oncology Volume: 42 Issue: 3 Pages: 224–227 Citations: 3 Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O. Year: 2020 Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960) Volume: 73 Issue: 5 Pages: 988–993 Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E. Year: 2019 Journal: Experimental Oncology Volume: 41 Issue: 1 Pages: 76–79
Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field. Research Interest Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies. Research Skills Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes. Award and Recognition Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise. Conclusion Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology. Publication Top Notes Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B. Year: 2024 Journal: Urologic Oncology: Seminars and Original Investigations Volume: 42 Issue: 2 Pages: 31.e9–31.e15 Citations: 1 Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E. Year: 2023 Journal: Journal of Cancer Research and Clinical Oncology Volume: 149 Issue: 7 Pages: 3131–3137 Citations: 1 Title: Modification of Fast-Track Surgery During Partial Nephrectomy Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O. Year: 2023 Journal: Ukrainian Journal of Nephrology and Dialysis Volume: 80 Issue: 4 Pages: 24–33 Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma Authors: Pikul, M.V., Stakhovsky, E.O. Year: 2023 Journal: Central European Journal of Urology Volume: 76 Issue: 2 Pages: 116–122 Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M. Year: 2022 Journal: Experimental Oncology Volume: 44 Issue: 1 Pages: 166–172 Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V. Year: 2021 Journal: Experimental Oncology Volume: 43 Issue: 2 Pages: 98–103 Citations: 1 Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O. Year: 2021 Journal: Advances in Urology Volume: 2021 Article ID: 6674637 Citations: 6 Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O. Year: 2020 Journal: Experimental Oncology Volume: 42 Issue: 3 Pages: 224–227 Citations: 3 Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O. Year: 2020 Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960) Volume: 73 Issue: 5 Pages: 988–993 Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E. Year: 2019 Journal: Experimental Oncology Volume: 41 Issue: 1 Pages: 76–79
Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award Posted on 22/08/202422/08/2024 by ScienceFather Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award Research Assistant of Tabriz university of medical sciences, Iran. Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award. Profile Scopus Profile ORCID Profile Education Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences. Professional Experience Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service. Research Interest Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery. Research Skills Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher. Awards and Recognition Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities. Conclusion Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award. Publications Top Notes Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P. Year: 2024 A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S. Year: 2024 Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful? Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J. Year: 2024 Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S. Year: 2023 Citations: 4 Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019 Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S. Year: 2023 Citations: 1 The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S. Year: 2022 Citations: 7 LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E. Year: 2021 Citations: 34 The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M. Year: 2021 Citations: 50 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M. Year: 2021 Citations: 79
Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.
Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.
Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.